Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Double Autologous Hematopoietic Stem Cell Transplantation With Sequential Use of Total Marrow Irradiation and High-dose Melphalan in Multiple Myeloma

NCT01665014 is registered in ClinicalTrials.gov with Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice as lead sponsor.

NCT NCT01665014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01665014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Double Autologous Hematopoietic Stem Cell Transplantation With Sequential Use of Total Marrow Irradiation and High-dose Melphalan in Multiple Myeloma
Lead sponsor
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2012
Completion date
August 31, 2016
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma